Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells.
Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells.
复制标题
DOI:
10.1080/15476286.2021.2010983
复制
发表时间:
2022
期刊:
影响因子:
4.1
通讯作者:
Yisraeli JK
中科院分区:
文献类型:
--
作者:
Wallis N;Oberman F;Shurrush K;Germain N;Greenwald G;Gershon T;Pearl T;Abis G;Singh V;Singh A;Sharma AK;Barr HM;Ramos A;Spiegelman VS;Yisraeli JK
Igf2bp1 is an oncofetal RNA binding protein whose expression in numerous types of cancers is associated with upregulation of key pro-oncogenic RNAs, poor prognosis, and reduced survival. Importantly, Igf2bp1 synergizes with mutations in Kras to enhance signalling and oncogenic activity, suggesting that molecules inhibiting Igf2bp1 could have therapeutic potential. Here, we isolate a small molecule that interacts with a hydrophobic surface at the boundary of Igf2bp1 KH3 and KH4 domains, and inhibits binding to Kras RNA. In cells, the compound reduces the level of Kras and other Igf2bp1 mRNA targets, lowers Kras protein, and inhibits downstream signalling, wound healing, and growth in soft agar, all in the absence of any toxicity. This work presents an avenue for improving the prognosis of Igf2bp1-expressing tumours in lung, and potentially other, cancer(s).
登录
查看更多内容
影响因子:
5
作者:
Glaß M;Misiak D;Bley N;Müller S;Hagemann S;Busch B;Rausch A;Hüttelmaier S
通讯作者:
Hüttelmaier S
影响因子:
8
作者:
Ghoshal A;Rodrigues LC;Gowda CP;Elcheva IA;Liu Z;Abraham T;Spiegelman VS
通讯作者:
Spiegelman VS
影响因子:
14.9
作者:
Dagil, Robert;Ball, Neil J.;Ramos, Andres
通讯作者:
Ramos, Andres
影响因子:
8
作者:
Bell, Jessica L.;Waechter, Kristin;Muehleck, Britta;Pazaitis, Nikolaos;Koehn, Marcel;Lederer, Marcell;Huettelmaier, Stefan
通讯作者:
Huettelmaier, Stefan
影响因子:
15.9
作者:
Chen, Chia-Lin;Tsukamoto, Hidekazu;Machida, Keigo
通讯作者:
Machida, Keigo